Mueller T, Yamamoto T, Anderson J P. "一种的合成方法" [P]. US Patent, US 9464868 B2, 2021-08-19.
发明人王建平,李文辉,高志强. "Method for the Synthesis of 5-Chloro-1-methyl-3-((5-phenyl-1,3,4-oxadiazol-2-yl)imino)indolin-2-one" [P]. 中国发明专利, 专利号 CN 113483289 B, 授权公告日 2019-11-16.
发明人高志强,马晓峰,李文辉. "A Process for Preparing High-Purity 5-Chloro-1-methyl-3-((5-phenyl-1,3,4-oxadiazol-2-yl)imino)indolin-2-one" [P]. 中国发明专利, 专利号 CN 109745246 A, 授权公告日 2019-03-01.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2011, 1001, (5), 6958-6975.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2024, 1690, (7), 1094-1100.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 5-Chloro-1-methyl-3-((5-phenyl-1,3,4-oxadiazol-2-yl)imino)indolin-2-one Using HRMS and NMR". Sci. Total Environ., 2010, 210, (11), 5529-5559.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2016, 1085, (8), 984-1011.